Market research
AY21.F Aytu BioScience, Inc
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 7M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.2
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Biotechnology
- ISIN
- Not available
- Market cap
- 7M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.2
About
About Aytu BioScience, Inc
Aytu BioScience, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally. The company markets Natesto, a nasal gel for the treatment of hypogonadism (low testosterone) in men; and Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension. It also offers ZolpiMist, an oral spray for the treatment of insomnia; and MiOXSYS, an in vitro diagnostic semen analysis test that is used in the measurement of static oxidation reduction potential in human semen. Aytu BioScience, Inc. is based in Englewood, Colorado.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the AY21.F discussion.
5 years, 5 months ago
Aytu BioScience, Inc is currently in a long term downtrend where the price is trading 93.6% below its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.1.
Aytu BioScience, Inc's total revenue rose by 839.0% to $14M since the same quarter in the previous year.
Its net income has increased by 12.6% to $-4M since the same quarter in the previous year.
Finally, its free cash flow fell by 166.9% to $-8M since the same quarter in the previous year.
Based on the above factors, Aytu BioScience, Inc gets an overall score of 3/5.